Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 11/20 | 0.60 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.37 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.37 |
| ▸ | FPR2 | P25090 | 3/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | CTSB | P07858 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.35 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953440 | 0.89 | AAK1 (0.51) | AAK1MMP1LMNARAB9A | |
| SCHEMBL30953339 | 0.87 | AAK1 (0.50) | AAK1CDK5DYRK1ACDK5R1MMP1 | |
| SCHEMBL30953319 | 0.87 | AAK1 (0.55) | AAK1GSK3BCDK5DYRK1ACDK5R1 | |
| SCHEMBL30953221 | 0.86 | AAK1 (0.48) | AAK1CDK5DYRK1ACDK5R1MMP1 | |
| SCHEMBL30953269 | 0.86 | AAK1 (0.48) | AAK1GSK3BMMP1LMNARAB9A | |
| SCHEMBL27393615 | 0.86 | AAK1 (0.48) | AAK1CDK5DYRK1ACDK5R1MMP1 | |
| SCHEMBL27393638 | 0.86 | AAK1 (0.48) | AAK1GSK3BMMP1LMNARAB9A | |
| SCHEMBL30953274 | 0.85 | AAK1 (0.48) | AAK1GSK3BMMP1LMNARAB9A | |
| SCHEMBL24103850 | 0.85 | AAK1 (0.58) | AAK1CDK5CDK5R1FPR2LMNA | |
| SCHEMBL30282565 | 0.85 | AAK1 (0.58) | AAK1CDK5CDK5R1FPR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |